Arthroplasty, Replacement, Shoulder
9
4
5
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
11%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
Which Factors Influence the Outcome After Anatomical and Reverse Shoulder Arthroplasty?
Intravenous Dexamethasone Administration in Patients Undergoing Total Shoulder Arthroplasty
Evaluation of Regeneten Augmentation for Subscapularis Healing After Total Shoulder Arthroplasty (RESTOR)
At Home, Digital Rehabilitation for Patients After Reverse Total Shoulder Arthroplasty
Testosterone Levels and Cutibacterium
Long Term Follow-up After Primary or Revision Shoulder Arthroplasty With a Patient- Specific Glenius Implant
Functional Outcomes and Quality of Life in Hip, Knee and Shoulder Arthroplasty
Does BIO-RSA Provides Superior Clinical Outcome Compared to Conventional RSA?
S-33 SMR Shoulder HP Reverse Glenosphere